Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV

Table 1 Baseline characteristics in 270 patients (mean±SD).

Variable factors	All patients (n = 270)	Recurrent patients (n = 136)	Recurrent patients (n = 136)
			Early phase (n = 107)	Late phase (n = 29)
Age (yr)	46.9±13.0	4.0±11.5	44.2±11.1	47.7±12.9
Sex (male/female)	247/23	126/10	Aug-99	27/2
Gross tumorclassification (small/solitary/nodular)	66/168/36	35/77/24	23/63/21	12/14/3
Edmondson classification (I-II/III-IV)	128/142	65/71	46/61	19/10
Tumor capsule (present/absent)	55/215	23/113	13/94	10/19
Vascular invasion (present/absent)	145/125	79/57	62/45	7/12
Alpha-fetoprotein (positive/negative)	141/129	85/51	75/32	10/19
Hepatocirrhosis (positive/negative)	200/70	105/31	82/25	23/6
Type of liver resection (non-anatomical/anatomical)	149/121	78/58	59/48	19/10
Incisal margin ( ≤1 cm/>1 cm)	22/258	15/131	14/93	1/28
HBV infection (positive/negative)	239/31	128/8	102/5	26/3
Blood transfusion (yes/no)	199/71	100/36	75/32	25/4
Survival time (d)	–	575.9±499.6	384.7±313.1	1248.5±450.9
Recurrent time (d)	–	435.6±417.9	23.1±199.6	1072.2±396.9

Note: Small HCC (SHCC), solitary large HCC (SLHCC), nodular HCC (NHCC).